Observation on the therapeutic effect of Shu Feng Huo Luo Pian for treatment of osseous arthritis.
OBJECTIVE
To evaluate the therapeutic effect of Chinese patent drug Shu Feng Huo Luo Pian ([symbol: see text] Pill for Dispelling Wind and Activating Collaterals) for the treatment of osseous arthritis.


METHODS
50 cases of osseous arthritis were divided randomly into two groups, the Shu Feng Huo Luo Pian group (the experimental group), including 30 cases (aged 63.5 +/- 4 years), treated with 2 such pills, p.o., bid; and the control group, including 19 cases (aged 63 +/- 5 years), treated with Sulindac 0.2 g, p.o., bid. The two groups were all supplemented by medication of calcium Caltrate D 0.6 g, p.o., qd. The above-mentioned medications were administered for 2 courses, 2 weeks constituting a course.


RESULTS
The total effective rate of the experimental group evaluated by the doctors was 83.3%, and that evaluated by the patients was 90%, with mild side effects.


CONCLUSIONS
Shu Feng Huo Luo Pian is an effective Chinese patent drug for treating osseous arthritis, with less and mild side effects.
Wu
Xiaosong
X
First Affiliated Hospital, Medical College, Jinan University, Guangzhou 510630.
Zhou
Yi
Y
D000368:Aged; D002118:Calcium / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D013467:Sulindac / Q000627:therapeutic use; D013607:Tablets; D014807:Vitamin D / Q000627:therapeutic use
D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; D013607:Tablets; D014807:Vitamin D; D013467:Sulindac; D002118:Calcium